Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nuclear reactor as a cancer cure

04.03.2005


Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.



A promising technology to more effectively treat certain cancers is Neutron Capture Therapy (NCT), a cutting-edge treatment method that uses neutrons captured during operation of a nuclear reactor to irradiate the tumor. A main advantage of NCT is the selective damage of tumor cells, avoiding many of the common severe side effects of other cancer treatment methods.

In the framework of a project (#1951) funded by the International Science and Technology Center, Russian scientists and researchers developed and implemented an experimental series of pre-clinical studies using NCT to treat melanoma in dogs. Research was carried out at a specially constructed irradiation room attached to the research reactor at the Moscow Institute of Physics (MEPhI), with scientists from MEPhI joined in their work by colleagues from SRC - Institute of Biophysics and the Russian Cancer Research Center.


The project results clearly demonstrate the effectiveness of NCT of inoculated tumors and spontaneous melanoma, with complete involution of tumor observed in 80% of cases.

The scientists and researchers of ISTC Project #1951 are eager to perform the necessary work in order to introduce NCT in clinical practice.

Professor Otto Harling from the Massachusetts Institute of Technology, and a collaborator on the ISTC Pro-ject, noted: "The Russian scientists have developed promising technologies to treat melanoma basing on in-tra-arterial administration of the compound into the tumor-feeding artery, and to treat osteo-sarcoma using BNCT of the removed neoplastic bone with subsequent reimplantation. The latter results are the first in the world and may find practical application in treating osteosarcoma in various sites."

Olga Myznikova | alfa
Further information:
http://www.istc.ru

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

Quantum optical sensor for the first time tested in space – with a laser system from Berlin

23.01.2017 | Physics and Astronomy

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>